Eyecontrol (961050)

  https://cordis.europa.eu/project/id/961050

  Horizon 2020 (2014-2020)

  EyeControl: A Communication Solution for Ventilated ICU Patients and Locked-in Individuals

  SME instrument (EIC-SMEInst-2018-2020)

  coronaviruses  ·  wearable medical technology

  2020-08-01 Start Date (YY-MM-DD)

  2022-07-31 End Date (YY-MM-DD)

  € 3,049,512 Total Cost

  Description

EyeFree Assisting Communication Ltd. developed the EyeControl, the first wearable, screenless assistive communication device. AI-powered eye-tracking technology enables communication between patients, medical staff and family, using only eye movements, without calibration or dependency on a screen or computer. EyeFree is changing reality, empowering autonomy among the Locked-in community by providing a round-the-clock communication solution that is operated independently by the user. EyeFree is expanding the scope of the recently finalized SME Phase 2 grant with the aim of developing additional improvements to the EyeControl technology, which will expedite medical facility market entry strategy. Short-term demand in this segment is growing; where an unmet need for communication in the ICU already existed, it has been further exasperated by an influx of ventilation caused by the Coronavirus. There is no solution on the market; and, that places the EyeControl at the forefront, as an immediate and effective assistive technology, facilitating easy and safe communication between patients, medical staff, caregivers, and families and leading to better quality patient care. Once this niche market has been consolidated, we will boost the market entry be known as the global communication platform for both ventilated and Locked-in patients, with two main product lines: EyeControl Home and Facility.

  Complicit Organisations

1 Israeli organisation participates in Eyecontrol.